Dianthus Therapeutics (DNTH) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChart

Dianthus Therapeutics Revenue Highlights


00

Dianthus Therapeutics Revenue by Period


Dianthus Therapeutics Revenue by Year

DateRevenueChange
2023-12-31--100.00%
2022-12-31$6.42M334.76%
2021-12-31$1.48M100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31--

Dianthus Therapeutics generated - in revenue during NA 2023, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Dianthus Therapeutics Revenue by Quarter

DateRevenueChange
2024-06-30--100.00%
2024-03-31$874.00K91.25%
2023-12-31$457.00K-50.54%
2023-09-30$924.00K100.00%
2023-06-30--100.00%
2023-03-31$476.00K-59.49%
2022-12-31$1.18M0.17%
2022-09-30$1.17M100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31--

Dianthus Therapeutics generated - in revenue during Q2 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

DNTH Revenue FAQ


Dianthus Therapeutics's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022. The company's yearly revenue for 2022 was $6.42M, representing an increase of 334.76% compared to 2021. DNTH's yearly revenue for 2021 was $1.48M, representing an increase of 100.00% compared to 2020.

Dianthus Therapeutics's quarterly revenue for Q2 2024 was $0, a -100.00% decrease from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $874K, a 91.25% increase from the previous quarter (Q4 2023), and a 83.61% increase year-over-year (Q1 2023). DNTH's quarterly revenue for Q4 2023 was $457K, a -50.54% decrease from the previous quarter (Q3 2023), and a -61.11% decrease year-over-year (Q4 2022).

Dianthus Therapeutics's revenue growth rate for the last 3 years (2021-2023) was -100.00%, and for the last 5 years (2019-2023) was 0%.